Publications by authors named "Jerry Clewell"

Claim this Profile
P
Psychosocial burden of axial spondyloarthritis and impact of different disease domains: a systematic literature review.
Denis Poddubnyy, Uta Kiltz, Abhijeet Danve, Grace Wright, Rebecca Haberman, Jerry Clewell

Rheumatol Adv Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases.
Min Yang, Manish Mittal, A Mark Fendrick, Diana Brixner, Bruce W Sherman, Jerry Clewell

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Jessica A Walsh, Shaobo Pei, Swetha Alexander, Tawnie Braaten, Jodi H Walker, Jerry Clewell

Semin Arthritis Rheum· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.
Martin J Bergman, Patrick Zueger, Jayeshkumar Patel, Christopher D Saffore, Ia Topuria, Jerry Clewell

Rheumatol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.
Martin Bergman, Namita Tundia, Min Yang, Eli Orvis, Jerry Clewell

Adv Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
Martin Bergman, Lili Zhou, Pankaj Patel, Ruta Sawant, Jerry Clewell

Adv Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.
Rishi J Desai, Seoyoung C Kim, Jeffrey R Curtis, Jaclyn L F Bosco, Bernadette Eichelberger, Jerry Clewell

Pharmacoepidemiol Drug Saf· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic review.
Matthew Sussman, Charles Tao, Pankaj Patel, Namita Tundia, Jerry Clewell

J Med Econ· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.
Jie Zhang, Gayathri Sridhar, Charles E Barr, Bernadette Eichelberger, Catherine M Lockhart, Jerry Clewell

J Manag Care Spec Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
Vibeke Strand, Ruchitbhai Shah, Chris Atzinger, Jifang Zhou, Jerry Clewell

Curr Med Res Opin· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Jessica A Walsh, Shaobo Pei, Gopi K Penmetsa, Brian C Sauer, Vikas Patil, Jerry Clewell

J Manag Care Spec Pharm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis.
Yan Song, Keith A Betts, Yichen Lu, Rakesh Singh, Jerry Clewell

Rheumatol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab).
Paul W Tebbey, Amy Varga, Michael Naill, Jerry Clewell, Jaap Venema

MAbs· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review.
Arijit Ganguli, Jerry Clewell, Alicia C Shillington

Patient Prefer Adherence· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting.
Woodie M Zachry, Quynhchau D Doan, Brien J Smith, Jerry D Clewell, Jenny M Griffith

Epilepsy Behav· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
Woodie M Zachry, Quynhchau D Doan, Jerry D Clewell, Brien J Smith

Epilepsia· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
Leslie L Citrome, Richard I G Holt, Woodie M Zachry, Jerry D Clewell, Paul A Orth

Ann Pharmacother· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments to the editor on "Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model".
Jerry D Clewell, Robert W Baker

Value Health· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis